Davenport & CO LLC Becton Dickinson & CO Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Davenport & CO LLC holds 366,460 shares of BDX stock, worth $83.4 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

366,460

Previous 223,340 64.08%

Holding current value

$83.4 Million

Previous $52.2 Million 69.27%

% of portfolio

0.53%

Previous 0.33%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$221.47 - $242.41 $31.7 Million - $34.7 Million	143,120 Added 64.08%	366,460 $88.4 Million
Q2 2024 Aug 06, 2024	SELL	$225.07 - $246.17 $526,663 - $576,037	-2,340 Reduced 1.04%	223,340 $52.2 Million
Q1 2024 May 03, 2024	BUY	$233.45 - $247.73 $50.7 Million - $53.8 Million	216,984 Added 2495.22%	225,680 $55.8 Million
Q4 2023 Jan 23, 2024	BUY	$232.24 - $267.23 $37,390 - $43,024	161 Added 1.89%	8,696 $2.12 Million
Q3 2023 Oct 17, 2023	SELL	$254.9 - $283.59 $575,054 - $639,779	-2,256 Reduced 20.91%	8,535 $2.21 Million
Q2 2023 Jul 20, 2023	SELL	$238.39 - $265.32 $102,269 - $113,822	-429 Reduced 3.82%	10,791 $2.85 Million
Q1 2023 Apr 27, 2023	BUY	$229.71 - $259.35 $8,039 - $9,077	35 Added 0.31%	11,220 $2.78 Million
Q4 2022 Jan 20, 2023	SELL	$218.29 - $256.91 $532,409 - $626,603	-2,439 Reduced 17.9%	11,185 $0
Q3 2022 Oct 11, 2022	SELL	$51.03 - $264.23 $87,006 - $450,512	-1,705 Reduced 11.12%	13,624 $3.04 Million
Q2 2022 Jul 18, 2022	BUY	$234.74 - $275.42 $413,611 - $485,290	1,762 Added 12.99%	15,329 $3.78 Million
Q1 2022 May 02, 2022	BUY	$243.64 - $270.48 $1.28 Million - $1.42 Million	5,260 Added 63.32%	13,567 $3.53 Million
Q4 2021 Feb 10, 2022	SELL	$230.08 - $250.94 $110,668 - $120,702	-481 Reduced 5.47%	8,307 $2.09 Million
Q3 2021 Oct 14, 2021	BUY	$232.72 - $256.47 $219,222 - $241,594	942 Added 12.01%	8,788 $2.16 Million
Q2 2021 Jul 28, 2021	SELL	$232.65 - $254.58 $73,284 - $80,192	-315 Reduced 3.86%	7,846 $1.91 Million
Q1 2021 Apr 28, 2021	SELL	$232.09 - $256.88 $46.7 Million - $51.7 Million	-201,346 Reduced 96.1%	8,161 $1.98 Million
Q4 2020 Jan 13, 2021	SELL	$221.92 - $245.94 $1.07 Million - $1.18 Million	-4,809 Reduced 2.24%	209,507 $52.4 Million
Q3 2020 Oct 15, 2020	SELL	$215.77 - $276.76 $147,586 - $189,303	-684 Reduced 0.32%	214,316 $49.9 Million
Q2 2020 Jul 28, 2020	BUY	$219.9 - $263.41 $133,919 - $160,416	609 Added 0.28%	215,000 $51.4 Million
Q1 2020 May 05, 2020	SELL	$195.69 - $279.01 $1.13 Million - $1.61 Million	-5,778 Reduced 2.62%	214,391 $49.3 Million
Q4 2019 Jan 22, 2020	BUY	$236.45 - $266.82 $20,807 - $23,480	88 Added 0.04%	220,169 $59.9 Million
Q3 2019 Oct 16, 2019	SELL	$230.58 - $256.08 $718,717 - $798,201	-3,117 Reduced 1.4%	220,081 $55.5 Million
Q2 2019 Jul 10, 2019	SELL	$217.4 - $246.08 $1.39 Million - $1.58 Million	-6,406 Reduced 2.79%	223,198 $56.2 Million
Q1 2019 Apr 17, 2019	BUY	$206.05 - $248.17 $11.9 Million - $14.3 Million	57,611 Added 33.5%	229,604 $57.3 Million
Q4 2018 Jan 28, 2019	SELL	$204.73 - $257.93 $228,683 - $288,107	-1,117 Reduced 0.65%	171,993 $38.8 Million
Q3 2018 Oct 11, 2018	BUY	$233.07 - $256.0 $687,323 - $754,944	2,949 Added 1.73%	173,110 $45.2 Million
Q2 2018 Jul 09, 2018	BUY	$208.1 - $233.85 $33.8 Million - $38 Million	162,572 Added 2142.21%	170,161 $40.8 Million
Q1 2018 Apr 04, 2018	SELL	$205.46 - $240.27 $71,705 - $83,854	-349 Reduced 4.4%	7,589 $1.64 Billion
Q4 2017 Jan 17, 2018	BUY	$189.0 - $222.64 $551,313 - $649,440	2,917 Added 58.1%	7,938 $1.7 Billion
Q3 2017 Oct 12, 2017	BUY	$186.89 - $198.9 $938,374 - $998,676	5,021	5,021 $984 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account